| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537126 | Vaccine | 2017 | 8 Pages |
Abstract
Alum, the most commonly used adjuvant, is contraindicated for transcutaneous vaccination via laser-generated micropores. TCI with optimized laser parameters induces high antibody titers, which cannot be significantly increased by the tested adjuvants. Commercially available vaccines formulated without alum have the potential for successful TCI via laser-generated micropores, without the need for reformulation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sandra Scheiblhofer, Anna Strobl, Veronika Hoepflinger, Theresa Thalhamer, Martin Steiner, Josef Thalhamer, Richard Weiss,